ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARLOS ORCES MD

Internal Medicine

6,416

$1.52M

548
422 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$237
Average prescription price

Avg: $67

MARK LINDEMANN DO

Internal Medicine

14,687

$867K

312
238 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

AGHA ABBAS MD

Internal Medicine

264

$4,188

158
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 27%

$16
Average prescription price

Avg: $67

VICTORIA CLAYTON MD

Internal Medicine

1,352

$56.6K

47
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $67

HUGO ROJAS MD, PA

Internal Medicine

16,362

$1.17M

805
318 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

AVIAN KIDD M.D.

Internal Medicine

4,224

$241K

194
160 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

PETE GARCIA M.D.

Internal Medicine

4,175

$268K

136
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

MOHAMEDAOUF KHAZNADAR MD

Internal Medicine

13,169

$697K

484
358 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

MIHAELA PERIJOC MD

Internal Medicine

7,333

$387K

316
241 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

LAWRENCE WHALEY MD

Internal Medicine

949

$29.1K

420
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$31
Average prescription price

Avg: $67

SADASIVAREDDY GOLI M.D.

Internal Medicine

6,584

$401K

287
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

SIEGFRIED KREIS M.D.

Internal Medicine

44,200

$2.75M

890
734 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

ANTHONY GAMBRAH MD. FACP

Internal Medicine

16,054

$845K

495
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

FIDELIS UNINI MD

Internal Medicine

6,337

$420K

321
177 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

ROY CAIVANO D.O

Internal Medicine

22,731

$1.57M

549
351 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

MARCOS REIS MD

Internal Medicine

6,192

$669K

316
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$108
Average prescription price

Avg: $67

ALMA AGUADO M.D.

Internal Medicine

7,069

$618K

385
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $67

CHRISTIAN OLYMPIA MD

Internal Medicine

473

$16.3K

135
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$34
Average prescription price

Avg: $67

PIOTR JAKUBOWSKI M.D.

Internal Medicine

871

$48.8K

69
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

ANAND BASI M.D.

Internal Medicine

7,590

$363K

428
268 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

ROBIN MCKELVEY MD

Internal Medicine

6,178

$2.89M

221
0 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 27%

$468
Average prescription price

Avg: $67

FIROOZEH KAR M.D.

Internal Medicine

24,815

$1.4M

508
446 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

LENIN PINNAMANENI M.D.

Internal Medicine

26,177

$1.23M

743
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

JAMES MOORE M.D.

Internal Medicine

1,249

$67.8K

204
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

JANE AYALA M.D.

Internal Medicine

1,918

$532K

167
103 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$278
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank